OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
First-In-Human Results On The Biodistribution, Pharmacokinetics, And Dosimetry of [177Lu]Lu-DOTA.SA.FAPi and [177Lu]Lu-DOTAGA.(SA.FAPi)2 in Patients with Various End-stage Cancers
Sanjana Ballal, Madhav Prasad Yadav, Euy Sung Moon, et al.
Research Square (Research Square) (2021)
Open Access | Times Cited: 17
Sanjana Ballal, Madhav Prasad Yadav, Euy Sung Moon, et al.
Research Square (Research Square) (2021)
Open Access | Times Cited: 17
Showing 17 citing articles:
Fibroblast activation protein-targeted radionuclide therapy: background, opportunities, and challenges of first (pre)clinical studies
Bastiaan M. Privé, Mohamed A. Boussihmad, Bart Timmermans, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2023) Vol. 50, Iss. 7, pp. 1906-1918
Open Access | Times Cited: 80
Bastiaan M. Privé, Mohamed A. Boussihmad, Bart Timmermans, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2023) Vol. 50, Iss. 7, pp. 1906-1918
Open Access | Times Cited: 80
Novel Fibroblast Activation Protein Inhibitor-Based Targeted Theranostics for Radioiodine-Refractory Differentiated Thyroid Cancer Patients: A Pilot Study
Sanjana Ballal, Madhav Prasad Yadav, Euy Sung Moon, et al.
Thyroid (2021)
Closed Access | Times Cited: 87
Sanjana Ballal, Madhav Prasad Yadav, Euy Sung Moon, et al.
Thyroid (2021)
Closed Access | Times Cited: 87
Clinical Advances and Perspectives in Targeted Radionuclide Therapy
Nicolas Lepareur, Barthélémy Ramée, Marie Mougin‐Degraef, et al.
Pharmaceutics (2023) Vol. 15, Iss. 6, pp. 1733-1733
Open Access | Times Cited: 32
Nicolas Lepareur, Barthélémy Ramée, Marie Mougin‐Degraef, et al.
Pharmaceutics (2023) Vol. 15, Iss. 6, pp. 1733-1733
Open Access | Times Cited: 32
Novel Generation of FAP Inhibitor-Based Homodimers for Improved Application in Radiotheranostics
Marcel Martin, Sanjana Ballal, Madhav Prasad Yadav, et al.
Cancers (2023) Vol. 15, Iss. 6, pp. 1889-1889
Open Access | Times Cited: 28
Marcel Martin, Sanjana Ballal, Madhav Prasad Yadav, et al.
Cancers (2023) Vol. 15, Iss. 6, pp. 1889-1889
Open Access | Times Cited: 28
New Frontiers in Cancer Imaging and Therapy Based on Radiolabeled Fibroblast Activation Protein Inhibitors: A Rational Review and Current Progress
Surachet Imlimthan, Euy Sung Moon, Hendrik Rathke, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 10, pp. 1023-1023
Open Access | Times Cited: 47
Surachet Imlimthan, Euy Sung Moon, Hendrik Rathke, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 10, pp. 1023-1023
Open Access | Times Cited: 47
Fibroblast Activation Protein Inhibitor (FAPI)-Based Theranostics—Where We Are at and Where We Are Heading: A Systematic Review
Marko Magdi Abdou Sidrak, Maria Silvia De Feo, Ferdinando Corica, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3863-3863
Open Access | Times Cited: 21
Marko Magdi Abdou Sidrak, Maria Silvia De Feo, Ferdinando Corica, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3863-3863
Open Access | Times Cited: 21
Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma or a Metaphor for Heterogeneity: From Single-Cell Analysis to Whole-Body Imaging
Rita Saúde-Conde, Ayça Arçay, Kosta Stosic, et al.
Biomedicines (2024) Vol. 12, Iss. 3, pp. 591-591
Open Access | Times Cited: 6
Rita Saúde-Conde, Ayça Arçay, Kosta Stosic, et al.
Biomedicines (2024) Vol. 12, Iss. 3, pp. 591-591
Open Access | Times Cited: 6
Head-to-Head Comparison between [68Ga]Ga-DOTA.SA.FAPi and [18F]F-FDG PET/CT Imaging in Patients with Breast Cancer
Sanjana Ballal, Madhav Prasad Yadav, Frank Roesch, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 4, pp. 521-521
Open Access | Times Cited: 16
Sanjana Ballal, Madhav Prasad Yadav, Frank Roesch, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 4, pp. 521-521
Open Access | Times Cited: 16
PET/CT with Fibroblast Activation Protein Inhibitors in Breast Cancer: Diagnostic and Theranostic Application—A Literature Review
Silvia Taralli, Margherita Lorusso, Elisabetta Perrone, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 908-908
Open Access | Times Cited: 15
Silvia Taralli, Margherita Lorusso, Elisabetta Perrone, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 908-908
Open Access | Times Cited: 15
From Automated Synthesis to In Vivo Application in Multiple Types of Cancer—Clinical Results with [68Ga]Ga-DATA5m.SA.FAPi
Lukas Greifenstein, Carsten S. Kramer, Euy Sung Moon, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 8, pp. 1000-1000
Open Access | Times Cited: 18
Lukas Greifenstein, Carsten S. Kramer, Euy Sung Moon, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 8, pp. 1000-1000
Open Access | Times Cited: 18
Performance and Prospects of [68Ga]Ga-FAPI PET/CT Scans in Lung Cancer
Paula E. Borgonje, Louise M. Andrews, Gerarda J.M. Herder, et al.
Cancers (2022) Vol. 14, Iss. 22, pp. 5566-5566
Open Access | Times Cited: 14
Paula E. Borgonje, Louise M. Andrews, Gerarda J.M. Herder, et al.
Cancers (2022) Vol. 14, Iss. 22, pp. 5566-5566
Open Access | Times Cited: 14
Recent Pre-Clinical Advancements in Nuclear Medicine: Pioneering the Path to a Limitless Future
William Echavidre, Daniel Fagret, Marc Faraggi, et al.
Cancers (2023) Vol. 15, Iss. 19, pp. 4839-4839
Open Access | Times Cited: 8
William Echavidre, Daniel Fagret, Marc Faraggi, et al.
Cancers (2023) Vol. 15, Iss. 19, pp. 4839-4839
Open Access | Times Cited: 8
Imageological/Structural Study regarding the Improved Pharmacokinetics by 68Ga-Labeled PEGylated PSMA Multimer in Prostate Cancer
Huihui Zhang, Maohua Rao, Huayi Zhao, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 4, pp. 589-589
Open Access | Times Cited: 6
Huihui Zhang, Maohua Rao, Huayi Zhao, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 4, pp. 589-589
Open Access | Times Cited: 6
Tailoring Fibroblast-Activation Protein Targeting for Theranostics: A Comparative Preclinical Evaluation of the 68Ga- and 177Lu-Labeled Monomeric and Dimeric Fibroblast-Activation Protein Inhibitors DOTA.SA.FAPi and DOTAGA.(SA.FAPi)2
Tilman Läppchen, Adrianna Bilinska, Eirinaios Pilatis, et al.
Molecules (2024) Vol. 29, Iss. 13, pp. 3093-3093
Open Access | Times Cited: 2
Tilman Läppchen, Adrianna Bilinska, Eirinaios Pilatis, et al.
Molecules (2024) Vol. 29, Iss. 13, pp. 3093-3093
Open Access | Times Cited: 2
[99mTc]Tc-iFAP Radioligand for SPECT/CT Imaging of the Tumor Microenvironment: Kinetics, Radiation Dosimetry, and Imaging in Patients
Luis Coria-Domínguez, Paola Vallejo-Armenta, Myrna Luna‐Gutiérrez, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 5, pp. 590-590
Open Access | Times Cited: 10
Luis Coria-Domínguez, Paola Vallejo-Armenta, Myrna Luna‐Gutiérrez, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 5, pp. 590-590
Open Access | Times Cited: 10
Associations between Normal Organs and Tumor Burden in Patients Imaged with Fibroblast Activation Protein Inhibitor-Directed Positron Emission Tomography
Aleksander Kosmala, Sebastian E. Serfling, Niklas Dreher, et al.
Cancers (2022) Vol. 14, Iss. 11, pp. 2609-2609
Open Access | Times Cited: 10
Aleksander Kosmala, Sebastian E. Serfling, Niklas Dreher, et al.
Cancers (2022) Vol. 14, Iss. 11, pp. 2609-2609
Open Access | Times Cited: 10
Fibroblast activation protein inhibitors: New frontier of molecular imaging and therapy
Venkatesh Rangarajan, Sayak Choudhury, Archi Agrawal, et al.
Elsevier eBooks (2022), pp. 755-773
Closed Access
Venkatesh Rangarajan, Sayak Choudhury, Archi Agrawal, et al.
Elsevier eBooks (2022), pp. 755-773
Closed Access
